Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effectiveness of Transference-Focused Psychotherapy for Borderline Personality Disorder
This study is currently recruiting participants.
Verified by University Hospital Muenster, July 2008
Sponsored by: University Hospital Muenster
Information provided by: University Hospital Muenster
ClinicalTrials.gov Identifier: NCT00714311
  Purpose

The purpose of this study is to find out whether Transference-Focused Psychotherapy (TFP) is effective in the treatment of Borderline Personality Disorder.


Condition Intervention
Borderline Personality Disorder
Behavioral: Transference-Focused Psychotherapy
Behavioral: Treatment as usual

MedlinePlus related topics: Personality Disorders
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Official Title: A Randomized-Controlled Trial of Transference-Focused Psychotherapy vs. Treatment as Usual for Borderline Personality Disorder

Further study details as provided by University Hospital Muenster:

Primary Outcome Measures:
  • Drop-out [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Suicidality (suicide attempts) [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Psychosocial Functioning (Global Assessment of Functioning, GAF-Score) [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Level of personality organization (Structured Interview for Personality Organization, STIPO) [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Number of self-harming acts [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Self-assessment of psychopathology (BDI, STAI, BSI) [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Attachment style and Reflective Function (Adult Attachment Interview, AAI) [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Borderline symptomatology (DSM-IV criteria) [ Time Frame: 1 month ] [ Designated as safety issue: No ]

Estimated Enrollment: 104
Study Start Date: October 2004
Estimated Study Completion Date: February 2012
Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
TFP: Active Comparator
Transference-Focused Psychotherapy
Behavioral: Transference-Focused Psychotherapy
Outpatient psychotherapy according to the treatment manual, sessions of 50 minutes twice per week
TAU: Active Comparator
Treatment as usual
Behavioral: Treatment as usual
Outpatient psychotherapy in private practices or outpatient units of psychiatric hospitals. Licensed psychotherapists are treating according to the method they have learned.

Detailed Description:

Borderline personality disorder represents a sever clinical condition that affects 1-2% of the community and is characterized by a pervasive instability of interpersonal relationships, self-image, and affects, as well as a marked impulsivity; up to 10% of the patients commit suicide.

Transference-Focused Psychotherapy (TFP) is one psychotherapeutic approach among five that have been manualized and evaluated in RCTs. So far, TFP has not been compared to treatment as usual which is a crucial step in the evaluation of the effectiveness of a psychosocial intervention.

This study is an RCT that compares one year of outpatient TFP to treatment as usual for borderline personality disorder.

  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Written informed consent to the participation in the study
  • Diagnosis of BPD according to DSM-IV as assessed using the SCID-II
  • Age between 18 and 45 years
  • Sufficient knowledge of the German language

Exclusion Criteria:

  • Diagnosis of schizophrenia, bipolar disorder, severe substance abuse, organic pathology, or mental retardation according to DSM-IV as assessed using the SCID-I
  • Diagnosis of antisocial personality disorder according to DSM-IV as assessed using the SCID-II
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00714311

Contacts
Contact: Stephan Doering, MD +49-251-83 ext 47074 stephan.doering@ukmuenster.de
Contact: Peter Buchheim, MD +49-15150402763 P.Buchheim@lrz.tu-muenchen.de

Locations
Austria
Dept. of Psychoanalysis and Psychotherapy, Medical University Vienna Recruiting
Vienna, Austria, 1090
Contact: Melitta Fischer-Kern, MD     +43-1-40400 ext 3069     melitta.fischer-kern@meduniwien.ac.at    
Contact: Peter Schuster, MD     +43-1-40400 ext 3073     peter.schuster@meduniwien.ac.at    
Principal Investigator: Peter Schuster, MD            
Sub-Investigator: Melitta Fischer-Kern, MD            
Germany, Bavaria
Dept. of Psychiatry, Technical University of Munich Recruiting
Munich, Bavaria, Germany, 81675
Contact: Michael Rentrop, MD     +49-89-4140 ext 4265     michael.rentrop@lrz.tu-muenchen.de    
Contact: Susanne Hoerz, PhD     +49-89-4140 ext 4142     hoerz@gmx.net    
Principal Investigator: Michael Rentrop, MD            
Sub-Investigator: Susanne Hoerz, PhD            
Sponsors and Collaborators
University Hospital Muenster
Investigators
Principal Investigator: Stephan Doering, MD University of Muenster, Germany
  More Information

Publications:
Responsible Party: University of Muenster, Germany ( Stephan Doering, MD )
Study ID Numbers: 1106/04, 10636, DPG0802
Study First Received: July 9, 2008
Last Updated: July 15, 2008
ClinicalTrials.gov Identifier: NCT00714311  
Health Authority: Germany: Ethics Commission

Keywords provided by University Hospital Muenster:
borderline personality disorder
randomized controlled trial
Transference-Focused Psychotherapy
treatment as usual

Study placed in the following topic categories:
Mental Disorders
Borderline Personality Disorder
Personality Disorders

Additional relevant MeSH terms:
Pathologic Processes
Disease

ClinicalTrials.gov processed this record on January 16, 2009